Identification of interleukin-4 (IL-4) targets in chronic lymphocytic leukemia (CLL)
Ontology highlight
ABSTRACT: Gene expression profiles of CLL cells and normal B cells (NBC) treated for 18 hr with 10 ng/ml IL-4, compared with culture with nothing (Ctrl) and the basal (Pre) samples. Patient CLL01 was also treated with IL-4 plus 5 mg/ml ERK activation inhibitor peptide I, or IL-4 plus 10 µM NFkB activation inhibitor, and IL-4 plus 100 mg/ml cyclic-pifithrin-α
ORGANISM(S): Homo sapiens
PROVIDER: GSE55288 | GEO | 2014/10/06
SECONDARY ACCESSION(S): PRJNA239211
REPOSITORIES: GEO
ACCESS DATA